JP2008530053A5 - - Google Patents

Download PDF

Info

Publication number
JP2008530053A5
JP2008530053A5 JP2007554570A JP2007554570A JP2008530053A5 JP 2008530053 A5 JP2008530053 A5 JP 2008530053A5 JP 2007554570 A JP2007554570 A JP 2007554570A JP 2007554570 A JP2007554570 A JP 2007554570A JP 2008530053 A5 JP2008530053 A5 JP 2008530053A5
Authority
JP
Japan
Prior art keywords
phenyl
pyridine
cyano
dihydro
thieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007554570A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008530053A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/050859 external-priority patent/WO2006084904A1/en
Publication of JP2008530053A publication Critical patent/JP2008530053A/ja
Publication of JP2008530053A5 publication Critical patent/JP2008530053A5/ja
Pending legal-status Critical Current

Links

JP2007554570A 2005-02-11 2006-02-10 癌の治療のための抗増殖性剤としてのテトラヒドロピリドチオフェン Pending JP2008530053A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05101007 2005-02-11
EP05104493 2005-05-25
EP05112159 2005-12-14
PCT/EP2006/050859 WO2006084904A1 (en) 2005-02-11 2006-02-10 Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2008530053A JP2008530053A (ja) 2008-08-07
JP2008530053A5 true JP2008530053A5 (https=) 2009-04-02

Family

ID=36143446

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007554570A Pending JP2008530053A (ja) 2005-02-11 2006-02-10 癌の治療のための抗増殖性剤としてのテトラヒドロピリドチオフェン

Country Status (6)

Country Link
US (1) US7741488B2 (https=)
EP (1) EP1851230A1 (https=)
JP (1) JP2008530053A (https=)
AU (1) AU2006212179A1 (https=)
CA (1) CA2596501A1 (https=)
WO (1) WO2006084904A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2309765T3 (es) 2004-05-28 2008-12-16 4Sc Ag Tetrahidropiridotiofenos.
US7714134B2 (en) 2004-06-11 2010-05-11 4Sc Ag Compounds and use of tetrahydropyridothiophenes
EP1851229A1 (en) 2005-02-09 2007-11-07 Nycomed GmbH Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
AU2006212179A1 (en) 2005-02-11 2006-08-17 4Sc Ag Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer
US7714136B2 (en) 2005-05-25 2010-05-11 4Sc Ag Tetrahydropyridothiophenes
US7763728B2 (en) 2005-05-25 2010-07-27 4Sc Ag Tetrahydropyridothiophenes
BR112020025696A2 (pt) 2018-06-19 2021-03-16 Novartis Ag Derivados de tetra-hidrotienopiridina n-substituída e usos dos mesmos

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE272078C (https=)
DE1225167B (de) * 1965-04-07 1966-09-22 Huels Chemische Werke Ag Verfahren zur Herstellung aliphatischer, aromatischer oder gemischt aliphatisch-aromatischer Sulfone
JPS5498337A (en) * 1978-01-06 1979-08-03 Dai Ichi Seiyaku Co Ltd Anticarcinogenic and/or antimetastatic agent
DE4039734A1 (de) 1990-12-13 1992-06-17 Basf Ag Substituierte 2-aminothiophene enthaltende herbizide mittel
GB9310700D0 (en) 1993-05-24 1993-07-07 Zeneca Ltd Novel composition
JP3074640B2 (ja) * 1995-12-22 2000-08-07 インターナショナル・ビジネス・マシーンズ・コーポレ−ション 液晶表示装置の駆動方法
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
HUP0104984A3 (en) * 1998-03-12 2003-07-28 Ontogen Corp Carlsbad Modulators of protein tyrosine phosphatases (ptpases) pharmaceutical compositions containing them and their use
WO1999046267A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
WO2000014090A1 (en) 1998-09-02 2000-03-16 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[2,3-c]pyridine derivatives
GB0114185D0 (en) 2001-06-12 2001-08-01 Protherics Molecular Design Lt Compounds
WO2002092076A1 (en) 2001-05-16 2002-11-21 Cytovia, Inc. Substituted coumarins and quinolines as caspases activators
US20040171603A1 (en) * 2001-05-18 2004-09-02 Janos Pato Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
WO2003084947A1 (en) 2002-04-09 2003-10-16 Axxima Pharmaceuticals Ag 4,5,6,7-tretrahydrobenzo[b] thiophene derivatives and methods for medical intervention against mycrobacterial infections
US20030232994A1 (en) * 2001-10-04 2003-12-18 Shao-Po Lu Bicyclic thiophene derivatives and combinatorial libraries thereof
NZ535959A (en) 2002-03-27 2006-05-26 Altana Pharma Ag Novel alkoxypyridine-derivatives as selective inhibitors of inducible nitric oxidase synthase NOS
JP4103425B2 (ja) * 2002-03-28 2008-06-18 セイコーエプソン株式会社 電気光学装置、電子機器及び投射型表示装置
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
DE60325985D1 (de) 2002-09-12 2009-03-12 Merck & Co Inc Substituierte bizyklische thiophen-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
CA2498399A1 (en) 2002-09-12 2004-03-25 Merck & Co., Inc. Method of treating diabetes and related conditions
TW200503994A (en) 2003-01-24 2005-02-01 Novartis Ag Organic compounds
IL154306A0 (en) 2003-02-05 2003-09-17 Rimonyx Pharmaceuticals Ltd Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof
US7138529B2 (en) 2003-04-16 2006-11-21 Hoffmann-La Roche Inc. Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
EP1670804A2 (en) 2003-09-10 2006-06-21 GPC Biotech AG Heterobicyclic compounds as pharmaceutically active agents
EA200600607A1 (ru) 2003-10-01 2006-10-27 Алтана Фарма Аг Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы
US20050085531A1 (en) 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
GB0324653D0 (en) 2003-10-22 2003-11-26 Syngenta Participations Ag Fungicides
US20050250794A1 (en) 2003-12-19 2005-11-10 Andrew Napper Methods of treating a disorder
US7745630B2 (en) * 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
SE0401970D0 (sv) 2004-08-02 2004-08-02 Astrazeneca Ab Novel compounds
EP1851229A1 (en) 2005-02-09 2007-11-07 Nycomed GmbH Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
AU2006212179A1 (en) 2005-02-11 2006-08-17 4Sc Ag Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer
US7763728B2 (en) 2005-05-25 2010-07-27 4Sc Ag Tetrahydropyridothiophenes
US7714136B2 (en) 2005-05-25 2010-05-11 4Sc Ag Tetrahydropyridothiophenes
WO2008020045A1 (en) 2006-08-16 2008-02-21 4Sc Ag Tetrahydrobenzothiophene derivatives

Similar Documents

Publication Publication Date Title
KR101546693B1 (ko) 치환된 퀴놀린 화합물 및 그 사용 방법
DK1692113T3 (en) ARYLIMIDAZOLES AND USE THEREOF AS ANTICANCES
US7196110B2 (en) N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
KR20200080254A (ko) 혈액학적 장애를 치료하기 위한 화합물 및 조성물
CN117715905A (zh) 检查点激酶1(chk1)抑制剂及其用途
AU2017273124B2 (en) Cancer treatments
CA2557433C (en) Quinazoline derivatives and therapeutic use thereof
JP2008512359A5 (https=)
JP2011510995A5 (https=)
KR20160104729A (ko) 암 또는 염증성 질환의 치료를 위한 치환 피롤로피리딘 및 피롤로피라진
ES2337558T3 (es) 4-h-cromenos sustituidos y analagos como activadores de caspasas e inductores de apoptosis y uso como agentes anticancerigenos.
AU2010319398B2 (en) Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
JP2008530053A5 (https=)
EP3288552A1 (en) Methods for treating cancer with a stat3 pathway inhibitor and kinase inhibitor
JP2008534637A5 (https=)
CN107708700A (zh) 用于治疗癌症的方法
JP2008542242A5 (https=)
CA2983013A1 (en) Methods for treating cancer
JP2008529989A5 (https=)
JP2025537926A (ja) Prmt5阻害剤及びmat2a阻害剤を使用する癌の処置
JP4599164B2 (ja) 3位が複素環式基によって置換されたピリドインドロン誘導体、それらの製造法およびそれらの治療用途
KR20040015138A (ko) 피리도인돌론 유도체 및 항암제 기재의 약제 조합물
KR20070106036A (ko) Bcr-abl 및 raf 억제제의 제약 조합물
HK40104383A (zh) 用於治疗血液病的化合物和组合物
JP2024521441A (ja) 化学療法関連の胃腸副作用を治療するための化合物及び方法